Andrea S. James serves as Executive at Insight Molecular Diagnostics Inc., where they oversee executive responsibilities. Since joining the company, Andrea S. James has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 31, 2025 involved exercising options for 50,000 shares valued at $0.
Andrea S. James currently holds 201,231 shares of Insight Molecular Diagnostics Inc. (IMDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrea S. James has been a net neutral trader of IMDX stock. They have purchased $0 and sold $0 worth of shares.
Andrea S. James's most recent insider trade was on Oct 31, 2025, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 31, 2025 | IMDX | $73.2K | Payment | 12,175 | $6.01 | Discretionary |